Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ryan D. Drant currently holds 7,488,893 shares of SUNESIS PHARMACEUTICALS INC (SNSS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ryan D. Drant has been a net seller of SNSS stock. They have purchased $105.7M and sold $226.3M worth of shares.
Ryan D. Drant's most recent insider trade was on Jun 5, 2015, when they purchased 1,869,159 shares at $10.70 per share.
Ryan D. Drant serves as Executive at SUNESIS PHARMACEUTICALS INC (SNSS). They have executed 301 insider transactions totaling $332.0M over their tenure at the company.
Ryan D. Drant holds the position of Executive at SUNESIS PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Ryan D. Drant has shown a selling trading pattern, with $105.7M in total purchases and $226.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Ryan D. Drant was on May 7, 2015, when they sold $109.7M worth of HPTX shares. This transaction involved 2,384,221 shares at $46.00 per share.
Ryan D. Drant currently owns 7,488,893 shares of SUNESIS PHARMACEUTICALS INC (SNSS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ryan D. Drant's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ryan D. Drant has 301 Form 4 filings on record as an insider at SUNESIS PHARMACEUTICALS INC.
Set alerts for Ryan D. Drant and 40,000+ other insiders.